Studies of the Toxicological Potential of Capsinoids, XIII: Inhibitory Effects of Capsaicin and Capsinoids on Cytochrome P450 3A4 in Human Liver Microsomes

被引:22
|
作者
Takanohashi, Toshiyuki [1 ]
Isaka, Mitsuyoshi
Ubukata, Kazuyuki
Mihara, Ryuichi
Bernard, Bruce K. [2 ]
机构
[1] Ajinomoto Co Inc, Pharmaceut Co, Pharmaceut Res Labs, Nonclin Dev Res Dept,Kawasaki Ku, Kanagawa, Japan
[2] SRA Int Inc, Cambridge, MD USA
关键词
capsaicin; capsinoids; human liver microsomes; cytochrome P450 3A4; CH-19 SWEET EXTRACT; COMMERCIAL-GRADE DIHYDROCAPSIATE; SINGLE-DOSE TOXICITY; IN-VITRO; DRUG-INTERACTIONS; 13-WEEK TOXICITY; CAPSICUM-ANNUUM; RATS; METABOLISM; PEPPER;
D O I
10.1177/1091581809360282
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study evaluated potential effects of a number of capsinoids (ie, capsiate, dihydrocapsiate, nordihydrocapsiate) and a single capsaicinoid (ie, capsaicin) on liver microsomal cytochrome P450 3A4-mediated midazolam I'-hydroxylase activity. Where possible, an inhibition curve was prepared; the concentration at which enzyme activity dropped to 50% was calculated. Capsaicin clearly inhibited cytochrome P450 3A4 activity, losing 50% of the activity at 21.5 mu mol/L. No enzyme inhibition was observed in the presence of capsiate, dihydrocapsiate, or nordihydrocapsiate (<100 mu mol/L). Preincubation increased the capsaicin inhibitory activity against cytochrome P450 3A4 in a time-dependent manner. Enzyme activity was slightly reduced by capsiate, dihydrocapsiate, and nordihydrocapsiate to the same level as that attained with tolbutamide, the negative control compound. Capsaicin was shown to inhibit cytochrome P450 3A4, probably through a mechanism-based inhibition. In contrast, capsiate, dihydrocapsiate, and nordihydrocapsiate did not inhibit cytochrome P450 3A4 activity and were unlikely to be mechanism-based inhibitors of CYP3A4.
引用
收藏
页码:22S / 26S
页数:5
相关论文
共 50 条
  • [31] Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids
    McNulty, James
    Nair, Jerald J.
    Singh, Mohini
    Crankshaw, Denis J.
    Holloway, Alison C.
    Bastida, Jaume
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (12) : 3233 - 3237
  • [32] Metabolic Activation of the Indoloquinazoline Alkaloids Evodiamine and Rutaecarpine by Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4
    Wen, Bo
    Roongta, Vikram
    Liu, Liling
    Moore, David J.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (06) : 1044 - 1054
  • [33] An evaluation of the cytochrome P450 inhibition potential of lisdexamfetamine in human liver microsomes
    Krishnan, Suma
    Moncrief, Scott
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (01) : 180 - 184
  • [34] Effects of chronic HBV infection on human hepatic cytochrome P450 3A4
    Li Shuang
    Miao Xiaohui
    Hu Zhuohan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A228 - A229
  • [35] Effects of human milk and formula on transcriptional regulation of cytochrome P450 3A4
    Rajesan, R
    Xu, HB
    Harper, PA
    Kim, RB
    Kliewer, SA
    Lonnerdal, BL
    Ito, S
    FASEB JOURNAL, 2004, 18 (05): : A1202 - A1202
  • [36] Involvement of human cytochrome P450 3A4 in the metabolism of vamidothion
    Mehmood, Z
    Kelly, DE
    Kelly, SL
    PESTICIDE SCIENCE, 1996, 46 (03): : 287 - 290
  • [37] Testosterone 1β-hydroxylation by human cytochrome P450 3A4
    Krauser, JA
    Voehler, M
    Tseng, LH
    Schefer, AB
    Godejohann, M
    Guengerich, FP
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (19): : 3962 - 3969
  • [38] Testosterone 1β-hydroxylation by human cytochrome P450 3A4
    Krauser, JA
    Voehler, M
    Tseng, LH
    Schefer, AB
    Godejohann, M
    Guengerich, FP
    DRUG METABOLISM REVIEWS, 2004, 36 : 254 - 254
  • [39] Molecular modeling of cytochrome P450 3A4
    Szklarz, GD
    Halpert, JR
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1997, 11 (03) : 265 - 272
  • [40] Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation
    Faucette, SR
    Hawke, RL
    Shord, SS
    Lecluyse, EL
    Lindley, CM
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (08) : 1123 - 1129